Safety Challenges in Blood Transfusion Systems in Low- and Middle-Income Countries: Implications for Public Health, Laboratory Quality, and Regulatory Oversight
Food and Drug Safety · 81-97 · 10.55121/fds.v3i2.101824
Blood transfusion represents a critical therapeutic intervention, and blood and blood components are increasingly recognised within biological product regulatory frameworks as regulated biological products. Nevertheless, maintaining blood transfusion safety in low- and middle-income countries (LMICs) remains a significant challe

